Patents by Inventor Marie-Pierre FLAMENT

Marie-Pierre FLAMENT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10813898
    Abstract: The invention pertains to a solid dosage form comprising vigabatrin; a superdisintegrant, advantageously chosen from the list consisting of crospovidone, a cellulose derivative and a starch derivative; a non-reducing sugar, advantageously chosen from the list consisting of mannitol, xylitol, and sorbitol; and a stearate derivative, advantageously a stearate or stearyl fumarate salt, more advantageously sodium stearyl fumarate or magnesium stearate.
    Type: Grant
    Filed: March 10, 2016
    Date of Patent: October 27, 2020
    Assignee: Orphelia Pharma
    Inventors: Charles Uzarama, Patrick Gosselin, Marie-Pierre Flament
  • Publication number: 20190070138
    Abstract: The invention pertains to a solid dosage form comprising vigabatrin; a superdisintegrant, advantageously chosen from the list consisting of crospovidone, a cellulose derivative and a starch derivative; a non-reducing sugar, advantageously chosen from the list consisting of mannitol, xylitol, and sorbitol; and a stearate derivative, advantageously a stearate or stearyl fumarate salt, more advantageously sodium stearyl fumarate or magnesium stearate.
    Type: Application
    Filed: March 10, 2016
    Publication date: March 7, 2019
    Inventors: Charles UZARAMA, Patrick GOSSELIN, Marie-Pierre FLAMENT